Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessResearch

Comparison of laboratory and immediate diagnosis of coagulation for patients under oral anticoagulation therapy before dental surgery

Birgit Kruse-Loesler email, Matthias Kelker email and Johannes Kleinheinz email

Department of Cranio-Maxillofacial Surgery, University of Muenster, Waldeyerstr. 30, D-48149 Muenster, Germany

author email corresponding author email

Head & Face Medicine 2005, 1:12doi:10.1186/1746-160X-1-12

Published: 29 November 2005

Abstract

Background

Dental surgery can be carried out on patients under oral anticoagulation therapy by using haemostyptic measures. The aim of the study was a comparative analysis of coagulation by laboratory methods and immediate patient diagnosis on the day of the planned procedure.

Methods

On the planned day of treatment, diagnoses were carried out on 298 patients for Prothrombin Time (PT), the International Normalised Ratio (INR), and Partial Thromboplastin Time (PTT). The decision to proceed with treatment was made with an INR < 4.0 according to laboratory results.

Results

Planned treatment did not go ahead in 2.7% of cases. Postoperatively, 14.8% resulted in secondary bleeding, but were able to be treated as out-patients. 1.7% had to be treated as in-patients. The average error between the immediate diagnosis and the laboratory method: 95% confidence interval was -5.8 ± 15.2% for PT, -2.7 ± 17.9 s for PTT and 0.23 ± 0.80 for INR. The limits for concordance were 9.4 and -21.1% for PT, 15.2 and -20.5 s for PTT, and 1.03 and -0.57 for INR.

Conclusion

This study showed a clinically acceptable concordance between laboratory and immediate diagnosis for INR. Concordance for PT and PTT did not meet clinical requirements. For patients under oral anticoagulation therapy, patient INR diagnosis enabled optimisation of the treatment procedure when planning dental surgery.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.